Home › Asset managers › Compare 2025-2026 › Vanguard vs American Century
Vanguard 2025-2026 · American Century 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 95,467 | 87,502 | 5,845 | 2,120 | 93.7% | 92.8% |
| Board proposals | 75,793 | 68,454 | 5,523 | 1,816 | 92.5% | 91.5% |
| E&S shareholder proposals | 173 | 149 | 3 | 21 | 98.0% | 96.7% |
| Other items | 19,501 | 18,899 | 319 | 283 | 98.3% | 97.9% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,816 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | American Century |
|---|---|---|---|---|---|---|
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of an amendment to our Certificate of Incorporation, as amended, to increase the total number of authorized shares of our common stock, par value $0.001 per share, from 220,000,000 shares to 440,000,000 shares. Capital Structure |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | Split 7 FOR, 3 AGAINST |
AGAINST 1 fund |
| 8x8, Inc. | July 25, 2025 | To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares. Compensation |
Board | For | Split 11 FOR, 1 AGAINST |
AGAINST 2 funds |
| 908 DEVICES INC | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST |
AGAINST 2 funds |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 24 FOR, 1 AGAINST |
AGAINST 6 funds |
| AAON, INC. | May 12, 2026 | Election of Directors for a term ending in 2029: Stephen O. LeClair Director Elections |
Board | For | Split 15 FOR, 1 AGAINST |
FOR 5 funds |
| ABACUS GLOBAL MANAGEMENT, INC. | June 3, 2026 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | Split 1 FOR, 12 AGAINST |
AGAINST 2 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 9 FOR, 1 AGAINST |
AGAINST 2 funds |
| ABERCROMBIE & FITCH CO. | June 3, 2026 | Advisory vote to approve the compensation of the Company's named executive officers for the fiscal year ended January 31, 2026. Say-on-Pay |
Board | For | Split 27 FOR, 6 AGAINST |
FOR 14 funds |
| ABM INDUSTRIES INCORPORATED | March 25, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026. Audit-related |
Board | For | Split 17 FOR, 4 AGAINST |
FOR 5 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | Split 28 FOR, 4 AGAINST |
AGAINST 6 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | Split 18 FOR, 4 AGAINST |
AGAINST 7 funds |
| ACCENDRA HEALTH, INC. | May 14, 2026 | Non-Binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 16 FOR, 2 AGAINST |
AGAINST 3 funds |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Arun Sarin Director Elections |
Board | For | Split 37 FOR, 1 AGAINST |
FOR 7 funds |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | Split 37 FOR, 1 AGAINST |
FOR 7 funds |
| ACCENTURE PLC | January 28, 2026 | To approve, in a non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 49 FOR, 9 AGAINST |
FOR 8 funds |
| ACCENTURE PLC | January 28, 2026 | To ratify, in a non-binding vote, the appointment of KPMG LLP ("KPMG") as independent auditor of Accenture and to authorize, in a binding vote, the Audit Committee of the Board of Directors to determine KPMG's remuneration. Audit-related |
Board | For | Split 43 FOR, 2 AGAINST |
FOR 7 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 7 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 3 funds |
| ACUMEN PHARMACEUTICALS, INC. | June 3, 2026 | To approve the Company's Amended and Restated 2021 Equity Incentive Plan. Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
AGAINST 1 fund |
| ADDUS HOMECARE CORPORATION | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 4 AGAINST |
FOR 4 funds |
| ADEIA INC. | May 7, 2026 | To approve an amendment to the Amended and Restated 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by an additional 10,700,000 shares of common stock; and Compensation |
Board | For | Split 20 FOR, 5 AGAINST |
FOR 8 funds |
| ADOBE INC. | April 15, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 33 FOR, 11 AGAINST |
AGAINST 12 funds |
| ADT Inc. | May 27, 2026 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt Director Elections |
Board | For | Split 24 FOR, 1 WITHHOLD |
WITHHOLD 7 funds |
| ADTRAN HOLDINGS, INC. | May 13, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 14 FOR, 2 AGAINST |
FOR 5 funds |
| ADVANCE AUTO PARTS, INC. | May 20, 2026 | Ratify the appointment of Deloitte & Touche LLP (Deloitte) as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 18 FOR, 6 AGAINST |
FOR 6 funds |
| ADVANCED DRAINAGE SYSTEMS, INC. | July 17, 2025 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | Split 26 FOR, 4 AGAINST |
Split 1 FOR, 8 AGAINST |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of an amendment to the Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 70,000,000 shares to 140,000,000 shares; Capital Structure |
Board | For | Split 17 FOR, 5 AGAINST |
FOR 6 funds |
| ADVANSIX INC | June 22, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for 2026. Audit-related |
Board | For | Split 9 FOR, 2 AGAINST |
FOR 8 funds |
| AEBI SCHMIDT HOLDING AG | May 21, 2026 | Election of Barend Fruithof as the Chair of the Board of Directors Corporate Governance |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 5 funds |
| AERCAP HOLDINGS N.V. | April 15, 2026 | Approve Report of the Nomination and Compensation Committee Say-on-Pay |
Board | For | Split 2 FOR, 3 AGAINST |
AGAINST 4 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | Split 2 FOR, 9 AGAINST |
AGAINST 7 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | Split 13 FOR, 1 AGAINST |
AGAINST 8 funds |
| AFFILIATED MANAGERS GROUP, INC. | May 27, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year. Audit-related |
Board | For | Split 22 FOR, 7 AGAINST |
FOR 7 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | Split 14 FOR, 3 AGAINST |
AGAINST 6 funds |
| AIA GROUP LTD | May 22, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | Split 9 FOR, 1 AGAINST |
FOR 10 funds |
| AIA GROUP LTD | May 22, 2026 | Approve KPMG as Auditors and Authorize Board to Fix Their Remuneration Audit-related |
Board | For | Split 9 FOR, 1 AGAINST |
FOR 10 funds |
| AIR CANADA | May 1, 2026 | ADVISORY VOTE ON EXECUTIVE COMPENSATION APPROACH Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 3 funds |
| AIRBNB INC | June 5, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 45 funds |
Split 8 FOR, 10 AGAINST |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | Split 17 FOR, 6 AGAINST |
FOR 10 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | Split 22 FOR, 6 AGAINST |
FOR 11 funds |
| AKERO THERAPEUTICS, INC | December 2, 2025 | To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. Say-on-Pay |
Board | Contested | Split 15 FOR, 1 AGAINST |
Split 5 FOR, 2 AGAINST |
| ALASKA AIR GROUP, INC. | May 12, 2026 | Approval (on an advisory basis) of the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | Split 24 FOR, 7 AGAINST |
FOR 14 funds |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | May 13, 2026 | To cast a non-binding, advisory vote on a resolution to approve the compensation of the Company's named executive officers, as more particularly described in the accompanying Proxy Statement. Say-on-Pay |
Board | For | Split 24 FOR, 4 AGAINST |
FOR 1 fund |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | Split 28 FOR, 7 AGAINST |
AGAINST 10 funds |
| ALIGOS THERAPEUTICS, INC. | June 25, 2026 | To approve an amendment to the Company's 2020 Employee Stock Purchase Plan (the "ESPP"), in substantially the form attached to the accompanying Proxy Statement as Appendix A, to remove the evergreen provision and increase the number of shares reserved for issuance under the ESPP by 500,000 shares. Compensation |
Board | For | Split 2 FOR, 1 AGAINST |
FOR 1 fund |
| ALKERMES PLC | May 20, 2026 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. Compensation |
Board | For | Split 25 FOR, 5 AGAINST |
FOR 17 funds |
| ALLEGRO MICROSYSTEMS, INC. | August 7, 2025 | To approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 23 FOR, 3 AGAINST |
FOR 3 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. Capital Structure |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 1 fund |
| ALLY FINANCIAL INC. | May 6, 2026 | Approval of the Ally Financial Inc. Incentive Compensation Omnibus Plan. Compensation |
Board | For | Split 28 FOR, 1 AGAINST |
FOR 9 funds |
| ALNYLAM PHARMACEUTICALS, INC. | May 20, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 30 FOR, 3 AGAINST |
FOR 13 funds |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | Split 26 FOR, 29 AGAINST |
FOR 26 funds |
| ALPHABET INC. | June 5, 2026 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock Compensation |
Board | For | Split 39 FOR, 9 AGAINST |
Split 10 FOR, 15 AGAINST |
| ALPHABET INC. | June 5, 2026 | Election of ten directors: Frances H. Arnold Director Elections |
Board | For | Split 28 FOR, 1 AGAINST |
Split 10 FOR, 15 AGAINST |
| ALPHABET INC. | June 5, 2026 | Election of ten directors: John L. Hennessy Director Elections |
Board | For | Split 28 FOR, 1 AGAINST |
Split 10 FOR, 15 AGAINST |
| ALPHABET INC. | June 5, 2026 | Election of ten directors: Robin L. Washington Director Elections |
Board | For | FOR 29 funds |
Split 15 FOR, 10 AGAINST |
| ALPHABET INC. | June 5, 2026 | Ratification of appointment of Ernst & Young LLP as Alphabet's independent registered public accounting firm for the fiscal year ending December 31, 2026 Audit-related |
Board | For | Split 51 FOR, 1 AGAINST |
FOR 25 funds |
| ALTA EQUIPMENT GROUP INC. | May 29, 2026 | To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive Plan Compensation |
Board | For | Split 7 FOR, 3 AGAINST |
AGAINST 4 funds |
| ALTO NEUROSCIENCE, INC. | May 12, 2026 | To approve an amendment and restatement of the Company's 2024 Employee Stock Purchase Plan to treat outstanding pre-funded warrants the same as outstanding shares of Common Stock for purposes of calculating the number of shares to be automatically added to the share reserve thereunder pursuant to the "evergreen" feature of the 2024 Employee Stock Purchase Plan. Capital Structure |
Board | For | Split 3 FOR, 1 AGAINST |
AGAINST 2 funds |
| AMAZON.COM, INC. | May 20, 2026 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS Audit-related |
Board | For | Split 48 FOR, 2 AGAINST |
FOR 24 funds |
| AMBARELLA, INC. | June 26, 2026 | To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | Split 15 FOR, 1 AGAINST |
AGAINST 3 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Advisory vote on Named Executive Officer compensation Say-on-Pay |
Board | For | Split 12 FOR, 2 AGAINST |
AGAINST 8 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026 Audit-related |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 7 funds |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Carl E. Vogel Director Elections |
Board | For | Split 6 FOR, 4 WITHHOLD |
WITHHOLD 7 funds |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Debra G. Perelman Director Elections |
Board | For | Split 6 FOR, 4 WITHHOLD |
WITHHOLD 7 funds |
| AMC Global Media Inc. | June 16, 2026 | Election of the following nominees as Directors: Matthew C. Blank Director Elections |
Board | For | Split 6 FOR, 4 WITHHOLD |
WITHHOLD 7 funds |
| AMERESCO, INC. (AMRC) | June 4, 2026 | Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified. Claire Hughes-Johnson Director Elections |
Board | For | Split 10 FOR, 1 WITHHOLD |
WITHHOLD 5 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve, on a non-binding, advisory basis, executive compensation as disclosed in the Proxy Statement for the 2026 Annual Meeting of Stockholders Say-on-Pay |
Board | For | Split 29 FOR, 5 AGAINST |
FOR 3 funds |
| AMERICAN EXPRESS COMPANY | May 5, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | Split 42 FOR, 4 AGAINST |
FOR 16 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | Split 43 FOR, 5 AGAINST |
FOR 11 funds |
| AMERICAN INTERNATIONAL GROUP, INC. | May 13, 2026 | Ratify Appointment of PricewaterhouseCoopers LLP to Serve as Independent Auditor for 2026. Audit-related |
Board | For | Split 33 FOR, 9 AGAINST |
FOR 10 funds |
| AMERICOLD REALTY TRUST, INC. | May 18, 2026 | Ratification of Ernst & Young LLP as our Independent Accounting Firm for 2026. Audit-related |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 4 funds |
| AMERIPRISE FINANCIAL, INC. | April 29, 2026 | To approve the compensation of the named executive officers by a nonbinding advisory vote. Say-on-Pay |
Board | For | Split 32 FOR, 11 AGAINST |
FOR 22 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | Split 16 FOR, 1 AGAINST |
AGAINST 2 funds |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | Split 21 FOR, 4 AGAINST |
FOR 7 funds |
| AMPLIFY ENERGY CORP. | June 3, 2026 | To approve the Amplify Energy Corp. 2024 Amended and Restated Equity Incentive Plan. Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 6 funds |
| AMUNDI SA | June 2, 2026 | RATIFY APPOINTMENT OF CLOTILDE L ANGEVIN AS DIRECTOR Director Elections |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 5 funds |
| AMUNDI SA | June 2, 2026 | RATIFY APPOINTMENT OF NICOLAS MAURE AS DIRECTOR Director Elections |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 5 funds |
| AMUNDI SA | June 2, 2026 | RATIFY APPOINTMENT OF PIERRE CAMBEFORT AS DIRECTOR Director Elections |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 5 funds |
| AMUNDI SA | June 2, 2026 | REELECT NICOLAS MAURE AS DIRECTOR Director Elections |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 5 funds |
| AMUNDI SA | June 2, 2026 | REELECT PIERRE CAMBEFORT AS DIRECTOR Director Elections |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 5 funds |
| ANALOG DEVICES, INC. | March 11, 2026 | Approve the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | Split 31 FOR, 6 AGAINST |
Split 10 FOR, 8 AGAINST |
| ANGI INC. | June 10, 2026 | Approval of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan. Compensation |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 1 fund |
| ANGI INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as Angi Inc.'s independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | Split 10 FOR, 1 AGAINST |
FOR 1 fund |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | Split 14 FOR, 4 AGAINST |
AGAINST 8 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 7 funds |
| ANTERIX INC. | August 5, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
AGAINST 1 fund |
| ANYWHERE REAL ESTATE INC. | January 7, 2026 | To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Anywhere's named executive officers that is based on or otherwise relates to the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | FOR 16 funds |
Split 1 FOR, 1 AGAINST |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 12 AGAINST |
FOR 6 funds |
| APOLLO GLOBAL MANAGEMENT, INC. | June 8, 2026 | An advisory vote to approve the compensation of AGM's named executive officers (Say on Pay); Say-on-Pay |
Board | For | Split 31 FOR, 1 AGAINST |
AGAINST 7 funds |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Mary Dean Hall Director Elections |
Board | For | Split 20 FOR, 1 WITHHOLD |
FOR 13 funds |
| APPLIED MATERIALS, INC. | March 12, 2026 | Ratification of the appointment of KPMG LLP as Applied Materials' independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | Split 36 FOR, 1 AGAINST |
FOR 20 funds |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | Split 13 FOR, 2 AGAINST |
AGAINST 4 funds |
| APPLOVIN CORPORATION | June 3, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 43 FOR, 2 AGAINST |
Split 12 FOR, 9 AGAINST |
| APTARGROUP, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | Split 24 FOR, 4 AGAINST |
FOR 7 funds |
| APTIV PLC | April 29, 2026 | Proposal to re-appoint auditors, ratify independent public accounting firm and authorize the directors to determine the fees paid to the auditors. Audit-related |
Board | For | Split 26 FOR, 7 AGAINST |
FOR 13 funds |
| ARCHER AVIATION INC. | June 26, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 14 FOR, 1 AGAINST |
AGAINST 2 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | Split 13 FOR, 1 WITHHOLD |
WITHHOLD 5 funds |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | Split 10 FOR, 5 AGAINST |
AGAINST 1 fund |
| ARES MANAGEMENT CORPORATION | June 8, 2026 | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our 2026 fiscal year. Audit-related |
Board | For | Split 24 FOR, 10 AGAINST |
FOR 3 funds |
Page 1 of 19 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.